198969-19-6 Usage
Description
(2R,4R)-4-Phenoxy-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl)-2-methylester, also known as Ramipril, is a medication belonging to the class of angiotensin-converting enzyme (ACE) inhibitors. It is used to treat high blood pressure and heart failure by relaxing blood vessels and reducing the workload on the heart. Ramipril works by inhibiting the ACE enzyme, which causes the body to retain fluid and constrict blood vessels. By blocking this enzyme, Ramipril helps to lower blood pressure and improve the heart's ability to pump blood effectively. It is typically taken orally in the form of a tablet and is available by prescription only.
Uses
Used in Pharmaceutical Industry:
Ramipril is used as an antihypertensive and heart failure treatment for managing high blood pressure and improving the heart's ability to pump blood effectively. It functions by inhibiting the ACE enzyme, leading to relaxation of blood vessels and reduced fluid retention in the body.
Common side effects of Ramipril include dizziness, cough, and increased blood potassium levels. It is important to consult a healthcare professional before using this medication, as it may interact with other drugs or medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 198969-19-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,9,6 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 198969-19:
(8*1)+(7*9)+(6*8)+(5*9)+(4*6)+(3*9)+(2*1)+(1*9)=226
226 % 10 = 6
So 198969-19-6 is a valid CAS Registry Number.
InChI:InChI=1/C17H23NO5/c1-17(2,3)23-16(20)18-11-13(10-14(18)15(19)21-4)22-12-8-6-5-7-9-12/h5-9,13-14H,10-11H2,1-4H3/t13-,14-/m1/s1
198969-19-6Relevant articles and documents
PYRROLIDINE GPR40 MODULATORS
-
Paragraph 00204, (2014/06/11)
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.